Beatrice Langton-webster
Oncology
Cancer Targeted Technology
United States of America
Biography
Dr. Beatrice Langton-Webster, CEO, and director, has over 30 years of experience in the biopharmaceutical industry with expertise in operational and executive management, licensing and strategic business development and preclinical & clinical cancer drug development. She helped bring to market: Betaseron® for multiple sclerosis, a HER-2 serum diagnostic kit for breast cancer and Fludara® for leukemia.
Research Interest
Oncology
